Screener/Healthcare/Biotechnology

ELVN

Enliven Therapeutics, Inc.NASDAQ
$34.74+3.57 (+11.46%)
Small CapUnder $50Healthcare
$13.30
$31.75
$33.76
$35.70
EPS (TTM)$-1.86
P/E Ratio—
Dividend Yield—
Market Cap$1.79B
Volume1.05M
Prev Close$31.15
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$0-$29.7M$-0.48——
Q3 '25$0-$20.1M$-0.32——
Q2 '25$0-$25.3M$-0.49——
Q1 '25$0-$28.5M$-0.57——
Q4 '24$0-$23.2M$-0.46——
Q3 '24$0-$23.2M$-0.48——
Q2 '24$0-$19.9M$-0.41——
Q1 '24$0-$22.7M$-0.54——
Get Your Daily Market Recap